RMD Open
is an open access, peer-reviewed rheumatology journal that publishes original research on rheumatic and musculoskeletal disorders and connective tissue diseases
Impact Factor: 6.2
Citescore: 7.7
All metrics >>
Latest Articles
Rheumatoid arthritis:
Classification of rheumatoid arthritis: is it time to revise the criteria?20 April 2024
Epidemiology:
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology20 April 2024
Lupus:
Polygenic Risk Score Predicts Earlier-Onset Adult Systemic Lupus Erythematosus and First-Year Renal Diseases in a Taiwanese Cohort18 April 2024
Video Abstract
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Conclusions: Bimekizumab demonstrated a safety profile consistent with previous reports; no new safety signals were identified. Sustained efficacy was observed from weeks 16 to 52.
Find out moreAltmetrics
Most Read Articles
Autoimmunity:
Association between sinusitis and incident rheumatic diseases: a population-based study22 February 2024
Rheumatoid arthritis:
Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants9 January 2024
Psoriatic arthritis:
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis31 January 2024